ARABIO was established in the year 2005 in saudi arabi  and is considered a leading company in manufacturing and marketing vaccines and biological products, in addition to conducting research.The company's factory began its production activities in 2011 with the production of a number of vaccines with support, cooperation and strategic partnerships with a number of international companies specialized in vaccines manufacturing. The factory was equipped with the latest machines to meet local and global requirements.ARABIO's capital amounted to SAR 186 million, of which ACDIMA owns 31.38%. Arabio focused their strategy on "Biological Business" that will support the creation of value over the long term for Arabio's shareholders and society by